Insider Transactions in Q1 2025 at Cor Medix Inc. (CRMD)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2025
|
Robert A Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+40.98%
|
-
|
|
Jan 17
2025
|
Alan W Dunton Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+38.31%
|
-
|
|
Jan 17
2025
|
Joseph Todisco Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,977
-4.84%
|
$287,724
$12.17 P/Share
|
|
Jan 17
2025
|
Joseph Todisco Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
187,500
+27.45%
|
-
|
|
Jan 17
2025
|
Steven W Lefkowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+19.92%
|
-
|
|
Jan 17
2025
|
Myron Kaplan Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+12.44%
|
-
|
|
Jan 17
2025
|
Janet Dillione Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+24.16%
|
-
|
|
Jan 17
2025
|
Gregory Scott Duncan Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Jan 10
2025
|
Erin Mistry EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,689
-5.33%
|
$62,579
$11.19 P/Share
|
|
Jan 10
2025
|
Joseph Todisco Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,829
-5.47%
|
$196,119
$11.19 P/Share
|
|
Jan 10
2025
|
Matthew T David Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,515
-6.4%
|
$71,665
$11.19 P/Share
|
|
Jan 10
2025
|
Elizabeth Masson Hurlburt EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
5,790
-4.76%
|
$63,690
$11.19 P/Share
|
|
Jan 02
2025
|
Kaufman Beth Zelnick Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,844
-9.01%
|
$94,752
$8.22 P/Share
|
|
Jan 02
2025
|
Kaufman Beth Zelnick Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+39.96%
|
-
|
|
Jan 02
2025
|
Matthew T David Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,648
-7.83%
|
$69,184
$8.22 P/Share
|
|
Jan 02
2025
|
Matthew T David Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+36.14%
|
-
|
|
Jan 02
2025
|
Elizabeth Masson Hurlburt EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
11,378
-8.56%
|
$91,024
$8.22 P/Share
|
|
Jan 02
2025
|
Elizabeth Masson Hurlburt EVP |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+39.7%
|
-
|
|
Jan 02
2025
|
Erin Mistry EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,830
-6.84%
|
$62,640
$8.22 P/Share
|
|
Jan 02
2025
|
Erin Mistry EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+35.31%
|
-
|